United States Biotechnology & Medical Research

Curis Inc (CRIS)

Track

Curis Inc. has seen no insider trading activity within the last three months. The most recent recorded transaction occurred on March 31, 2026, when Kenneth I. Kaitin purchased 10,000 shares. Prior to this, historical records indicate various planned sales by executives, though these events date back several years.
Ticker: CRIS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Curis Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 31 Mar 2026
Value US$628,079.91 | Price 96.78 | Shares 19,804 (+15.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-01 2026-03-31 B Purchase
1.4
KAITIN KENNETH I
Non-Executive Director
19,804 +15.2%
96.78
US$628,080 		19,804 +15.2% 96.78 US$628,080
2022-01-31 2022-01-31 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
7,694 +19.5%
241.08
US$3,894,184 		7,694 +19.5% 241.08 US$3,894,184
2022-01-31 2022-01-27 S Sale
3.5
Dentzer James E

President & CEO

Executive Director
76,558 -48.4%
430.09
US$3,139,785 		76,558 -48.4% 430.09 US$3,139,785
2021-01-26 2021-01-26 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
3,094 -4.4%
10.59
US$32,758 		3,094 -4.4% 10.59 US$32,758
2021-01-26 2021-01-25 S Sale
3.5
Dentzer James E

President & CEO

Executive Director
2,283 -3.1%
10.96
US$25,022 		2,283 -3.1% 10.96 US$25,022
2020-01-24 2020-01-24 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
3,094 -6.8%
1.64
US$5,076 		3,094 -6.8% 1.64 US$5,076
2020-01-24 2020-01-23 S Sale
3.5
Dentzer James E

President & CEO

Executive Director
3,658 -7.5%
1.69
US$6,182 		3,658 -7.5% 1.69 US$6,182
2019-01-25 2019-01-24 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
3,094 -6.9%
1.16
US$3,577 		3,094 -6.9% 1.16 US$3,577
2019-01-25 2019-01-23 PlS Planned sale
3.5
Dentzer James E

President & CEO

Executive Director
2,397 -5.1%
1.09
US$2,613 		2,397 -5.1% 1.09 US$2,613
2019-01-25 2019-01-23 PlS Planned sale
GREENACRE MARTYN D
Non-Executive Director
18,500 -41.5%
1.05
US$19,475 		18,500 -41.5% 1.05 US$19,475
2019-01-25 2019-01-23 PlS Planned sale
Martell Robert

Head of Research & Development

Officer
5,500 -19.3%
1.07
US$5,900 		5,500 -19.3% 1.07 US$5,900
2019-01-25 2019-01-23 PlS Planned sale
1.4
KAITIN KENNETH I
Non-Executive Director
14,800 -34.5%
1.05
US$15,587 		14,800 -34.5% 1.05 US$15,587
2019-01-25 2019-01-23 PlS Planned sale
Kunkel Lori Anne
Non-Executive Director
14,800 -40.0%
1.05
US$15,581 		14,800 -40.0% 1.05 US$15,581
2019-01-25 2019-01-23 PlS Planned sale
Rubin Marc
Non-Executive Director
18,500 -39.1%
1.05
US$19,477 		18,500 -39.1% 1.05 US$19,477
2017-11-16 2017-11-16 B Purchase Rubin Marc
25,000 +94.0%
0.98
US$24,500 		25,000 +94.0% 0.98 US$24,500
2017-11-15 2017-11-15 B Purchase Fattaey Ali Ph.D.

President & CEO

Executive Director
50,000 +75.9%
1.06
US$53,000 		50,000 +75.9% 1.06 US$53,000
2017-05-05 2017-05-05 PlS Planned sale MCNAB JAMES R Non-Executive Director
16,176 -24.4%
1.90
US$30,721 		16,176 -24.4% 1.90 US$30,721
2017-05-05 2017-05-04 PlS Planned sale MCNAB JAMES R Non-Executive Director
30,100 -31.3%
1.97
US$59,159 		30,100 -31.3% 1.97 US$59,159
2017-05-05 2017-05-03 PlS Planned sale MCNAB JAMES R Non-Executive Director
30,000 -23.8%
2.18
US$65,544 		30,000 -23.8% 2.18 US$65,544
2017-05-02 2017-05-02 PlS Planned sale MCNAB JAMES R Non-Executive Director
35,646 -22.0%
2.31
US$82,314 		35,646 -22.0% 2.31 US$82,314
2017-05-02 2017-05-01 PlS Planned sale MCNAB JAMES R Non-Executive Director
38,113 -19.1%
2.38
US$90,709 		38,113 -19.1% 2.38 US$90,709
2017-05-02 2017-04-28 PlS Planned sale MCNAB JAMES R Non-Executive Director
42,949 -17.7%
2.45
US$105,015 		42,949 -17.7% 2.45 US$105,015
2017-04-27 2017-04-27 PlS Planned sale MCNAB JAMES R
37,202 -13.3%
2.57
US$95,624 		37,202 -13.3% 2.57 US$95,624
2017-04-27 2017-04-26 PlS Planned sale MCNAB JAMES R
19,814 -6.6%
2.65
US$52,442 		19,814 -6.6% 2.65 US$52,442
2017-04-27 2017-04-26 PlS Planned sale MCNAB JAMES R
32,738 -3.6%
2.65
US$86,648 		32,738 -3.6% 2.65 US$86,648
2017-04-27 2017-04-25 PlS Planned sale MCNAB JAMES R
56,940 -5.9%
2.60
US$148,306 		56,940 -5.9% 2.60 US$148,306
2017-04-24 2017-04-24 PlS Planned sale MCNAB JAMES R
42,076 -3.2%
2.56
US$107,862 		42,076 -3.2% 2.56 US$107,862
2017-04-24 2017-04-21 PlS Planned sale MCNAB JAMES R
45,705 -3.4%
2.58
US$117,841 		45,705 -3.4% 2.58 US$117,841
2017-04-24 2017-04-20 PlS Planned sale MCNAB JAMES R
22,541 -1.6%
2.66
US$59,979 		22,541 -1.6% 2.66 US$59,979
2016-09-09 2016-09-07 B Purchase Aurigene Discovery Technologies Ltd Large shareholder
10,208,333 +59.6%
2.40
US$24,499,999 		10,208,333 +59.6% 2.40 US$24,499,999
2016-05-27 2016-05-27 S Sale GREENACRE MARTYN D Non-Executive Director
10,000 -22.1%
1.69
US$16,900 		10,000 -22.1% 1.69 US$16,900
2016-05-27 2016-05-27 S Sale GREENACRE MARTYN D Non-Executive Director
5,000 -12.4%
1.69
US$8,450 		5,000 -12.4% 1.69 US$8,450
2016-05-27 2016-05-26 S Sale KAITIN KENNETH I Non-Executive Director
10,000 -27.2%
1.76
US$17,600 		10,000 -27.2% 1.76 US$17,600
2016-05-27 2016-05-26 S Sale KAITIN KENNETH I Non-Executive Director
5,000 -15.7%
1.76
US$8,800 		5,000 -15.7% 1.76 US$8,800
2015-12-30 2015-12-30 PlS Planned sale PASSERI DANIEL R Non-Executive Director
14,400 -6.8%
3.01
US$43,344 		14,400 -6.8% 3.01 US$43,344
2015-12-30 2015-12-29 PlS Planned sale PASSERI DANIEL R Non-Executive Director
11,200 -5.3%
2.91
US$32,592 		11,200 -5.3% 2.91 US$32,592
2015-12-29 2015-12-28 PlS Planned sale PASSERI DANIEL R Non-Executive Director
11,000 -5.2%
2.84
US$31,240 		11,000 -5.2% 2.84 US$31,240
2015-12-29 2015-12-24 PlS Planned sale PASSERI DANIEL R Non-Executive Director
2,600 -1.3%
2.90
US$7,540 		2,600 -1.3% 2.90 US$7,540
2015-12-23 2015-12-23 PlS Planned sale PASSERI DANIEL R Non-Executive Director
10,900 -5.2%
2.90
US$31,610 		10,900 -5.2% 2.90 US$31,610
2015-12-23 2015-12-22 PlS Planned sale PASSERI DANIEL R Non-Executive Director
38,000 -16.0%
2.75
US$104,500 		38,000 -16.0% 2.75 US$104,500
2015-12-21 2015-12-21 PlS Planned sale PASSERI DANIEL R Non-Executive Director
100,000 -33.5%
2.87
US$287,000 		100,000 -33.5% 2.87 US$287,000
2015-12-21 2015-12-18 PlS Planned sale PASSERI DANIEL R Non-Executive Director
189,000 -48.7%
3.05
US$576,450 		189,000 -48.7% 3.05 US$576,450
2014-08-28 2014-08-27 B Purchase Fattaey Ali Ph.D.

President & CEO

Executive Director
62,890 +2096.3%
1.60
US$100,624 		62,890 +2096.3% 1.60 US$100,624
2013-12-12 2013-12-11 B Purchase Fattaey Ali Ph.D.

President & COO

Officer
3,000 +inf%
2.52
US$7,560 		3,000 +inf% 2.52 US$7,560
2013-11-12 2013-11-12 B Purchase GRAY MICHAEL

CFO

Officer
10,000 +10.3%
2.86
US$28,600 		10,000 +10.3% 2.86 US$28,600
2013-11-08 2013-11-08 B Purchase Pienta Kenneth Non-Executive Director
20,000 +200.0%
2.95
US$59,000 		20,000 +200.0% 2.95 US$59,000
2013-11-08 2013-09-16 B Purchase Pienta Kenneth Non-Executive Director
10,000 +inf%
4.37
US$43,691 		10,000 +inf% 4.37 US$43,691
2013-08-19 2013-08-16 S Sale MCNAB JAMES R Non-Executive Director
50,000 -50.0%
4.00
US$200,000 		50,000 -50.0% 4.00 US$200,000
2013-08-19 2013-08-16 B Purchase MCNAB JAMES R Non-Executive Director
50,000 +25.0%
4.00
US$200,000 		50,000 +25.0% 4.00 US$200,000
2013-05-08 2013-05-08 S Sale PASSERI DANIEL R

CEO and Director

Officer
86,852 -30.4%
3.70
US$321,352 		86,852 -30.4% 3.70 US$321,352
2013-05-08 2013-05-07 S Sale PASSERI DANIEL R

CEO and Director

Officer
40,000 -16.7%
3.63
US$145,200 		40,000 -16.7% 3.63 US$145,200
2013-05-06 2013-05-06 S Sale PASSERI DANIEL R

CEO and Director

Officer
60,000 -21.6%
3.66
US$219,600 		60,000 -21.6% 3.66 US$219,600
2013-05-06 2013-05-03 S Sale PASSERI DANIEL R

CEO and Director

Officer
65,000 -30.1%
3.73
US$242,450 		65,000 -30.1% 3.73 US$242,450
2013-05-06 2013-05-02 S Sale PASSERI DANIEL R

CEO and Director

Officer
50,000 -24.9%
3.66
US$183,000 		50,000 -24.9% 3.66 US$183,000
2013-05-03 2013-05-02 S Sale GREENACRE MARTYN D Non-Executive Director
60,000 -63.1%
3.67
US$220,200 		60,000 -63.1% 3.67 US$220,200
2013-05-03 2013-05-02 S Sale NOEL MARK

VP, Tech Management

Officer
17,742 -39.2%
3.66
US$64,936 		17,742 -39.2% 3.66 US$64,936
2013-05-03 2013-05-02 S Sale NOEL MARK

VP, Tech Management

Officer
52,258 -65.5%
3.66
US$191,264 		52,258 -65.5% 3.66 US$191,264
2012-12-07 2012-12-06 B Purchase PASSERI DANIEL R

CEO and Director

Officer
25,000 +19.9%
3.03
US$75,750 		25,000 +19.9% 3.03 US$75,750
2012-09-21 2012-09-19 S Sale GREENACRE MARTYN D Non-Executive Director
50,000 -58.7%
4.31
US$215,500 		50,000 -58.7% 4.31 US$215,500
2012-09-21 2012-09-18 PlS Planned sale GRAY MICHAEL

COO and CFO

Officer
26,250 -23.3%
4.28
US$112,350 		26,250 -23.3% 4.28 US$112,350
2012-08-03 2012-08-01 PlS Planned sale NOEL MARK

VP, Tech Management

Officer
48,000 -63.5%
4.74
US$227,520 		48,000 -63.5% 4.74 US$227,520
2012-06-19 2012-06-19 S Sale MCNAB JAMES R Non-Executive Director
139,000 -11.4%
4.76
US$661,640 		139,000 -11.4% 4.76 US$661,640
2012-06-19 2012-06-18 S Sale MCNAB JAMES R Non-Executive Director
150,000 -11.0%
4.75
US$712,500 		150,000 -11.0% 4.75 US$712,500
2012-06-19 2012-06-15 S Sale MCNAB JAMES R Non-Executive Director
11,000 -0.8%
4.73
US$52,030 		11,000 -0.8% 4.73 US$52,030
2012-05-02 2012-05-01 PlS Planned sale NOEL MARK

VP, Tech Management

Officer
37,687 -57.8%
4.78
US$180,144 		37,687 -57.8% 4.78 US$180,144
2012-05-02 2012-05-01 PlS Planned sale NOEL MARK

VP, Tech Management

Officer
36,413 -56.9%
4.78
US$174,054 		36,413 -56.9% 4.78 US$174,054
2012-05-02 2012-05-01 PlS Planned sale PASSERI DANIEL R

CEO and Director

Officer
36,000 -22.3%
4.80
US$172,800 		36,000 -22.3% 4.80 US$172,800
2012-05-02 2012-04-30 PlS Planned sale PASSERI DANIEL R

CEO and Director

Officer
16,813 -11.8%
4.83
US$81,207 		16,813 -11.8% 4.83 US$81,207
2012-05-02 2012-04-30 PlS Planned sale PASSERI DANIEL R

CEO and Director

Officer
57,837 -31.5%
4.83
US$279,353 		57,837 -31.5% 4.83 US$279,353
2012-04-20 2012-04-19 PlS Planned sale GRAY MICHAEL

COO and CFO

Officer
2,421 -2.7%
5.01
US$12,129 		2,421 -2.7% 5.01 US$12,129
2012-04-20 2012-04-18 PlS Planned sale GRAY MICHAEL

COO and CFO

Officer
40,423 -31.8%
5.01
US$202,519 		40,423 -31.8% 5.01 US$202,519
2012-03-29 2012-03-28 S Sale GREENACRE MARTYN D Non-Executive Director
80,000 -69.5%
4.92
US$393,600 		80,000 -69.5% 4.92 US$393,600
2011-12-27 2011-12-23 PlS Planned sale BAYH SUSAN B Non-Executive Director
29,705 -54.3%
4.50
US$133,672 		29,705 -54.3% 4.50 US$133,672
2011-05-11 2011-05-11 B Purchase KAITIN KENNETH I Non-Executive Director
6,800 +34.0%
3.68
US$25,024 		6,800 +34.0% 3.68 US$25,024
2011-04-01 2011-03-31 S Sale PASSERI DANIEL R

CEO and Director

Officer
98,100 -60.1%
3.25
US$318,825 		98,100 -60.1% 3.25 US$318,825
Explore more

More insider trading research around Curis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America